Adverse dermatologic reactions to transdermal drug delivery systems.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 2112162.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transdermal drug delivery systems are marketed in the United States for four different drugs, and others are in various stages of development. Cutaneous side effects occur frequently with these systems and sometimes necessitate discontinuation of therapy. This article will review these adverse reactions.
Medical subject headings
- Administration, Cutaneous
- Dermatitis, Contact